Telix Pharmaceuticals Limited · ASX:TLX
Behrenbruch Christian bought 67,935 Telix Pharmaceuticals Limited shares (Form 4)
Traded Apr 28 to Apr 29, 2026 · Filed May 6, 2026
From Apr 28 to Apr 29, 2026, Behrenbruch Christian (Director, MD & Group CEO) bought 67,935 Telix Pharmaceuticals Limited shares at an average US$14.67 for US$997K, leaving 20,742,935 shares. Filed May 6, 2026 (Form 4).
- Bought
- 67,935 shares
- Price
- US$14.67 average (US$14.48 to US$14.87)
- Value
- US$997K
- Holding after
- 20,742,935 shares (held indirectly)
- Trading plan
- No
- Role
- Director, MD & Group CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | Ordinary Shares | Buy | 34,500 | US$14.48 | 20,709,500 | Indirect |
| Apr 29, 2026 | Ordinary Shares | Buy | 33,435 | US$14.87 | 20,742,935 | Indirect |